Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Direct and indirect costs for yersiniosis and shigellosis in Sweden

In English

Författare

Summary, in English

Yersiniosis and shigellosis are two bacteria-borne and food-related diseases that lead to significant costs in terms of direct costs (costs of healthcare, medicine, rehabilitation etc.), indirect costs (lost productivity due to absenteeism) and intangible costs (pain, nausea and other intangible aspects that can be linked to disease). It is essential to estimate these costs, partly to be able to compare the disease burden of various diseases, and partly to evaluate the effectiveness of using different measures aimed at reducing the burden of disease.



The purpose of this report is to estimate the direct and indirect costs of yersiniosis and shigellosis including the two sequelae reactive arthritis (ReA) and inflammatory bowel syndrome (IBS). Intangible costs require other methods to calculate and are not included in this analysis. However, it is possible to combine the findings of this report with an independent analysis of the intangible costs to obtain a more complete cost picture for the diseases.

Publiceringsår

2012

Språk

Svenska

Publikation/Tidskrift/Serie

AgriFood Economics Report

Dokumenttyp

Rapport

Förlag

[Publisher information missing]

Ämne

  • Health Care Service and Management, Health Policy and Services and Health Economy

Nyckelord

  • reactive arthritis
  • cost-of-illness
  • yersiniosis
  • shigellosis
  • inflammatory bowel syndrome

Status

Published

Report number

4